Resources

1 Resources for

baronova inc.

Subscribe to this listing via:
RSS
Email

BNET Resources

The GlaxoSmithKline-Allergan Deal Worst-Case Scenario: Allergan's stock has risen on an item from DealReporter.com outlining acquisition discussions with GlaxoSmithKline. Allergan surged $5.41, or 13 percent, to $48.58, per Bloomberg, on the news. As usual, at BNET we ask: before the money gets spent, what's the worst-case scenario? The first...; Tags: Allergan Inc., GlaxoSmithKline Plc., GSK, BAROnova Inc., Sales Strategy, Mergers & Acquisitions, Sales, Investment, Finance, Jim Edwards; Blog posts 2009-03-25

<< Previous
page 1 of 1
Next >>

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors

Your Work Five Ways to Speak Like Obama

Five Ways to Speak Like Obama

Barack Obama is a master at grabbing and keeping his audience's attention, which is the number one goal of any public speaker. How does he do it? Here are five key lessons from Obama's rhetorical playbook.
Your Industry Northrop Sells TASC Unit in Conflict-Avoidance Move

Northrop Sells TASC Unit in Conflict-Avoidance Move

Northrop Grumman has come to an agreement to sell their SETA line for $1.65 billion. This is due to worries about conflicts of interest limits newly tightened by the Federal Government may cost the company contracts and revenue.
Your Money 29 Fees We Hate Most

29 Fees We Hate Most

An increasing number of businesses, from hotels to cell phone providers, are advertising bargain prices and then tacking on hidden fees and charges to boost the final cost. Here’s how you can fight back.